医学
奥利斯特
芬特明
肥胖
癌症
不利影响
肥胖管理
糖尿病
西布曲明
重症监护医学
内科学
减肥
内分泌学
作者
Krushna K. Zambare,Arun A. Kondapure,Kailasam Koumaravelou,Shrinivas B. Bumrela
出处
期刊:Research Journal of Pharmacy and Technology
[Diva Enterprises Private Limited]
日期:2020-10-12
卷期号:13 (10): 4966-4966
被引量:1
标识
DOI:10.5958/0974-360x.2020.00871.9
摘要
Obesity is major health problem worldwide. It is widely accepted that increase in obesity results from an imbalance between energy intake and expenditure. Obesity can increase the risk of type 2 diabetes, ischemic heart disease, stroke, and cancer Obesity is associated with increased death rates from a wide variety of human cancers, including colon and rectum, esophagus, kidney, pancreas, gallbladder, ovary, cervix, liver, prostate, and certain hematopoietic cancers. It is necessary to treat obese individuals by both lifestyle interventions and/or pharmacological or surgical therapy. Unfortunately, the drug therapy gives short-term benefits, is can cause rebound weight gain after the cessation of drug use, side effects and adverse effects from the drug, and drug abuse. Pharmacological treatment includes diethylpropion, sibutramine, orlistat, phentermine, and fluoxetineor bupropion. This review aimed to investigate the herbal medicines available in the management of obesity.
科研通智能强力驱动
Strongly Powered by AbleSci AI